Feb. 22, 2008

Stem Cells May Treat Diabetes

Scientists Coax Embryonic Stem Cells To Treat Mice With A Condition Similar To Type 1 Diabetes

  • In lab tests on mice, scientists at a San Diego company called Novocell grafted human embryonic stem cells into abdominal fat in mice.

    In lab tests on mice, scientists at a San Diego company called Novocell grafted human embryonic stem cells into abdominal fat in mice.  (CBS/AP)

  • Interactive Stem Cell Research

    Follow the debate, and learn how and why the cells are harvested.

  • Special Report Diabetes

    Symptoms, treatments, and how to prevent it.

(WebMD)  Researchers report using embryonic stem cells to treat a condition like Type 1 diabetes in mice.

Stem cells are cells that can develop into other types of cells. Embryonic stem cells can develop into a wide range of cell types.

In lab tests on mice, scientists at a San Diego company called Novocell grafted human embryonic stem cells into abdominal fat in mice. Before being implanted into the mice, those stem cells had been prepped to develop into pancreatic cells that get killed in type 1 diabetes.

Thirty days after implantation, the embryonic stem cells had morphed into pancreatic cells. And about two months after that, those pancreatic cells were up to speed at producing insulin, a hormone that controls blood sugar.

The experiment proves the potential for embryonic stem cells to treat Type 1 diabetes, note the researchers, who included Emmanuel Baetge, Ph.D.

But the process isn't yet ready for use in people.

Of the 46 grafts that Baetge's team transplanted into the mice, seven led to tumors. Scientists worldwide are working on ways to harness the potential of stem cells while minimizing health risks from stem cell treatment.

Baetge and colleagues report their findings online in Nature Biotechnology.

By Miranda Hitti
Reviewed by Louise Chang
©2005-2006 WebMD, Inc. All rights reserved.
Share:
  • Share
  • Yahoo! Buzz
  • Mixx
Add a Comment
by rf35 February 22, 2008 4:53 PM EST
Wow. If a cure for diabetes is developed, Big Pharma will have a cow. Diabetes patients are customers for life as things stand today. Big Pharma is strongly opposed to stem cell research because it could offer cures instead of long-term treatments. There just isn''t as much profit in cures. I wonder if they are behind most of the arguements against stem cell research, especially embryonic stem cells.
Reply to this comment
  • MOST POPULAR
Discussed
  1. Kennedy: Bishop Barred Me From Communion

    (337 recent comments)

Latest News
News in Pictures
Scroll Left Scroll Right
Connect with CBS News

Stay connected with the CBS News using your favorite social networks and online news applications: